BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9541629)

  • 1. Effect of ornithine in parenteral nutrition regimens on difluoromethylornithine-induced platelet suppression and changes in tumor polyamine content.
    Grossie VB; Nishioka K
    Cancer Invest; 1998; 16(3):160-5. PubMed ID: 9541629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced tissue ornithine increases the cytotoxicity of difluoromethylornithine.
    Grossie VB; Nishioka K
    Anticancer Res; 1996; 16(6B):3731-5. PubMed ID: 9042249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A parenteral nutrition regimen with ornithine substituted for arginine alters the amino acid, but not polyamine, content of the ward colon tumor.
    Grossie VB; Nishioka K
    Nutr Cancer; 1997; 27(1):102-6. PubMed ID: 8970190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of difluoromethylornithine on host and tumor polyamine metabolism during total parenteral nutrition.
    Harris WB; Grossie VB; Ota DM; Nishioka K; Ajani JA; Chang T; Patenia D
    J Surg Res; 1985 Jun; 38(6):592-8. PubMed ID: 3925242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituting ornithine for arginine in total parenteral nutrition eliminates enhanced tumor growth.
    Grossie VB; Nishioka K; Ajani JA; Ota DM
    J Surg Oncol; 1992 Jul; 50(3):161-7. PubMed ID: 1619938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citrulline and arginine increase the growth of the Ward colon tumor in parenterally fed rats.
    Grossie VB
    Nutr Cancer; 1996; 26(1):91-7. PubMed ID: 8844725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyamine-directed preferential nutritional repletion of normal tissues in tumor-bearing hosts.
    Nishioka K; Grossie VB; Ajani JA; Patenia D; Chang TH; Ota DM
    Int J Cancer; 1988 Nov; 42(5):744-7. PubMed ID: 3141298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of thrombocytopenia with concomitant ornithine in sarcoma-bearing rats receiving high dose difluoromethylornithine.
    Grossie VB; Ota DM; Ajani JA; Nishioka K
    Invest New Drugs; 1991 Nov; 9(4):321-6. PubMed ID: 1804805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of difluoromethylornithine-induced thrombocytopenia in rats with ornithine while maintaining antitumor activity.
    Grossie VB; Ota DM; Ajani JA; Chang TH; Patenia D; Nishioka K
    Cancer Res; 1989 Aug; 49(15):4159-62. PubMed ID: 2501023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intravenous alpha-difluoromethylornithine on the polyamine levels of normal tissue and a transplantable fibrosarcoma.
    Grossie VB; Ota DM; Ajani JA; Nishioka K
    Cancer Res; 1987 Apr; 47(7):1836-40. PubMed ID: 3102050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-alpha-difluoromethylornithine.
    Merali S; Clarkson AB
    Antimicrob Agents Chemother; 1996 Apr; 40(4):973-8. PubMed ID: 8849262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell polyamine levels and host toxicity during continuous alpha-difluoromethylornithine infusion.
    Ota DM; Grossie VB; Ajani JA; Stephens LC; Nishioka K
    Int J Cancer; 1986 Aug; 38(2):245-9. PubMed ID: 3089944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyamine metabolism in Pneumocystis carinii.
    Lipschik GY; Masur H; Kovacs JA
    J Infect Dis; 1991 May; 163(5):1121-7. PubMed ID: 2019760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary polyamines promote the growth of azoxymethane-induced aberrant crypt foci in rat colon.
    Paulsen JE; Reistad R; Eliassen KA; Sjaastad OV; Alexander J
    Carcinogenesis; 1997 Oct; 18(10):1871-5. PubMed ID: 9363993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of tumor and parenteral nutrition on jejunal mucosal polyamines.
    Chance WT; Noguchi Y; Zhang X; Hasselgren PO; Fischer JE
    Nutr Cancer; 1995; 23(1):23-32. PubMed ID: 7739912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of alpha-difluoromethylornithine on the in vivo uptake of 14C-labeled polyamines and methylglyoxal bis(guanylhydrazone) by a rat prostate-derived tumor.
    Heston WD; Kadmon D; Covey DF; Fair WR
    Cancer Res; 1984 Mar; 44(3):1034-40. PubMed ID: 6420052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of difluoromethylornithine on proliferation, polyamine content and plating efficiency of cultured human carcinoma cells.
    Seidenfeld J
    Cancer Chemother Pharmacol; 1985; 15(3):196-202. PubMed ID: 3931927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention.
    Meyskens FL; Gerner EW; Emerson S; Pelot D; Durbin T; Doyle K; Lagerberg W
    J Natl Cancer Inst; 1998 Aug; 90(16):1212-8. PubMed ID: 9719082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in polyamine metabolism during continuous intravenous infusion of alpha-difluoromethylornithine showing correlation of thrombocytopenia with alpha-difluoromethylornithine plasma levels.
    Ajani JA; Ota DM; Grossie VB; Levin B; Nishioka K
    Cancer Res; 1989 Oct; 49(20):5761-5. PubMed ID: 2507135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ornithine aminotransferase activity, tissue ornithine concentrations and polyamine metabolism.
    Seiler N; Daune G; Bolkenius FN; Knödgen B
    Int J Biochem; 1989; 21(4):425-32. PubMed ID: 2501116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.